journal article·2024-06-12

Fabrication, evaluation, and enhanced penetration of vinyl and cellulose-engineered transdermal patch of nifedipine using essential oil as penetration enhancer

Stabak Das, Sudip Das, Sanjib Bahadur, Maitreyee Mukherjee, Gouranga Nandi, Sreejan Manna

Publisher page

Abstract

The aim of this study was to develop and evaluate the transdermal patch formulations of nifedipine. The patch formulations containing nifedipine were prepared and optimized with different ratios of vinyl and cellulose-derived polymers, drug contents, and permeation enhancers. Among the various formulations, the patch formulation containing a 1:5 ratio of ethyl cellulose and polyvinyl pyrrolidone was selected for ex vivo pharmacokinetic study based on in vitro permeation studies using stratum corneum of the pig’s skin. The cumulative percentage release after the transdermal administration of the optimized patch formulation was 71.43%, and the plasma concentration of nifedipine was maintained for 16 hrs. The physicochemical evaluation study including flatness, thickness, moisture content and uptake, drug content in vitro release, and ex vivo permeation indicated satisfactory results. The formulation batch with clove oil as a penetration enhancer has shown better ex vivo permeation as compared to the formulations without enhancers and another synthetic enhancer. These results suggest that the optimized patch formulation Q3 could be further developed for clinical applications, providing the therapeutic plasma level of nifedipine over an extended period. Hence analyzing the results of the evaluation tests, in vitro and ex vivo data on the preparation and optimization of nifedipine-loaded transdermal patch, it can be concluded that the formulation shows its feasibility as an effective transdermal delivery system for nifedipine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Essential Oils and Antimicrobial Activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Technology, Brainware University, Barasat, India

Department of Pharmaceutics, Himalayan Pharmacy Institute, Majhitar, India

Division of Pharmaceutics, Department of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur, Dist, Darjeeling, India

References (74)

Show source-provided references
1. 10.1038/nbt.150410.1038/nbt.1504 ↗
2. 10.1016/j.jconrel.2023.02.00610.1016/j.jconrel.2023.02.006 ↗
3. 10.1038/nrd130410.1038/nrd1304 ↗
4. 10.1016/j.apmt.2022.10172610.1016/j.apmt.2022.101726 ↗
5. 10.1038/s41598-022-14463-910.1038/s41598-022-14463-9 ↗
6. 10.3390/pharmaceutics1508202910.3390/pharmaceutics15082029 ↗
7. 10.9734/jpri/2021/v33i35B3189710.9734/jpri/2021/v33i35B31897 ↗
8. 10.1186/s40824-021-00226-610.1186/s40824-021-00226-6 ↗
9. 10.1016/j.ejps.2022.10616910.1016/j.ejps.2022.106169 ↗
10. 10.1007/s13346-021-00909-610.1007/s13346-021-00909-6 ↗
11. 10.1016/j.ajps.2019.04.00610.1016/j.ajps.2019.04.006 ↗
12. 10.1021/acs.molpharmaceut.3c0012610.1021/acs.molpharmaceut.3c00126 ↗
13. 10.1515/bmt-2019-001910.1515/bmt-2019-0019 ↗
14. 10.1002/smll.20230167010.1002/smll.202301670 ↗
15. 10.1016/j.mtchem.2020.10038210.1016/j.mtchem.2020.100382 ↗
16. 10.3390/polym1205111410.3390/polym12051114 ↗
17. 10.1016/j.jddst.2020.10228410.1016/j.jddst.2020.102284 ↗
18. 10.1039/c7tb02529g10.1039/c7tb02529g ↗
19. 10.3389/fbioe.2021.64655410.3389/fbioe.2021.646554 ↗
20. 10.1080/09205063.2022.215577810.1080/09205063.2022.2155778 ↗
21. 10.1039/C6RA27476E10.1039/C6RA27476E ↗
22. 10.3390/ma1609341710.3390/ma16093417 ↗
23. Saidin NM, Anuar NK. Meor mohd affandi MMR. Roles of polysaccharides in transdermal drug delivery system and future prospects. J Appl Pharm Sci. Open Science Publishers LLP Inc. 2018;8(3):141–157.
24. 10.1021/ie403619b10.1021/ie403619b ↗
25. 10.3389/fmats.2022.83550710.3389/fmats.2022.835507 ↗
26. 10.3109/10717544.2014.90588210.3109/10717544.2014.905882 ↗
27. 10.1016/j.ijpx.2019.10002310.1016/j.ijpx.2019.100023 ↗
28. 10.3390/gels903020110.3390/gels9030201 ↗
29. 10.3390/polym1320345510.3390/polym13203455 ↗
30. 10.1016/j.jddst.2021.10271510.1016/j.jddst.2021.102715 ↗
31. 10.1161/HYPERTENSIONAHA.120.1502610.1161/HYPERTENSIONAHA.120.15026 ↗
32. 10.1016/j.molliq.2021.11775910.1016/j.molliq.2021.117759 ↗
33. 10.1016/j.jsps.2013.12.01910.1016/j.jsps.2013.12.019 ↗
34. 10.1016/j.jddst.2022.10411710.1016/j.jddst.2022.104117 ↗
35. 10.1080/09205063.2023.223084710.1080/09205063.2023.2230847 ↗
36. Manna S Nandi G Jana S. Alginate-based Carriers for Transdermal Drug Delivery. In: Jana S Jana S Domb A J editor. Polysaccharide-based Biomaterials: Delivery of Therapeutics and Biomedical Applications. The Royal Society of Chemistry 2022. p. 69–89.10.1039/9781839166235-00069 ↗
37. 10.4103/aam.aam_11_2010.4103/aam.aam_11_20 ↗
38. 10.1007/s00228-022-03382-310.1007/s00228-022-03382-3 ↗
39. 10.1016/j.ijpharm.2022.12242510.1016/j.ijpharm.2022.122425 ↗
40. 10.1016/j.colsurfb.2022.11247410.1016/j.colsurfb.2022.112474 ↗
41. 10.1016/j.ejpb.2022.11.00410.1016/j.ejpb.2022.11.004 ↗
42. 10.1016/j.bbamem.2009.08.01510.1016/j.bbamem.2009.08.015 ↗
43. 10.1016/j.xphs.2022.08.02710.1016/j.xphs.2022.08.027 ↗
44. 10.22159/ajpcr.2017.v10i9.1938910.22159/ajpcr.2017.v10i9.19389 ↗
45. 10.1111/jphp.1233410.1111/jphp.12334 ↗
46. 10.3109/1061186X.2015.111653810.3109/1061186X.2015.1116538 ↗
47. 10.1081/ddc-12002871610.1081/ddc-120028716 ↗
48. 10.3109/03639045.2012.65764310.3109/03639045.2012.657643 ↗
49. 10.1081/ddc-12001863810.1081/ddc-120018638 ↗
50. 10.1186/s40543-016-0105-610.1186/s40543-016-0105-6 ↗
51. 10.1007/s10924-018-1305-510.1007/s10924-018-1305-5 ↗
52. 10.2147/IJN.S8025310.2147/IJN.S80253 ↗
53. 10.1208/s12249-020-01793-y10.1208/s12249-020-01793-y ↗
54. 10.1007/s12272-013-0073-y10.1007/s12272-013-0073-y ↗
55. 10.3109/10717544.2014.93553210.3109/10717544.2014.935532 ↗
56. 10.1080/17425247.2020.171308710.1080/17425247.2020.1713087 ↗
57. 10.1007/s00289-021-03559-310.1007/s00289-021-03559-3 ↗
58. 10.1081/ddc-10010836810.1081/ddc-100108368 ↗
59. 10.1186/s43094-019-0008-710.1186/s43094-019-0008-7 ↗
60. 10.1016/j.msec.2020.11154410.1016/j.msec.2020.111544 ↗
61. 10.22270/jddt.v9i1-s.232610.22270/jddt.v9i1-s.2326 ↗
62. 10.1016/j.jconrel.2021.11.02510.1016/j.jconrel.2021.11.025 ↗
63. 10.1016/j.matpr.2022.06.15610.1016/j.matpr.2022.06.156 ↗
64. 10.1371/journal.pone.022890810.1371/journal.pone.0228908 ↗
65. 10.1007/s13318-022-00778-510.1007/s13318-022-00778-5 ↗
66. 10.1016/j.ijpharm.2018.11.03210.1016/j.ijpharm.2018.11.032 ↗
67. 10.1016/j.chemphyslip.2019.10479410.1016/j.chemphyslip.2019.104794 ↗
68. 10.1016/j.ejps.2021.10591510.1016/j.ejps.2021.105915 ↗
69. 10.1016/j.ijpharm.2019.11888610.1016/j.ijpharm.2019.118886 ↗
70. 10.1016/j.sjbs.2021.08.08810.1016/j.sjbs.2021.08.088 ↗
71. 10.1021/acsomega.1c0114110.1021/acsomega.1c01141 ↗
72. 10.1080/09205063.2023.228603310.1080/09205063.2023.2286033 ↗
73. 10.1080/17425247.2022.204594410.1080/17425247.2022.2045944 ↗
74. 10.1080/13880209.2017.131246410.1080/13880209.2017.1312464 ↗